Kegley gets 30 months for part in drug-compounding ring

Michael Kegley Jr., a former sales representative for the Kentucky compounding pharmacy Medivet, was sentenced to 30 months in prison on Thursday by a federal judge in New York, according to court documents, the latest in a string of sentences handed down to individuals connected to racing who were indicted nearly two years ago.

Kegley, who entered a guilty plea to one charge of conspiracy to commit drug adulteration or misbranding last year, was sentenced one day after his brother-in-law, Kristian Rhein, a racetrack vet, was sentenced to three years in prison on the same charge. The two were indicted along with 25 other individuals in March of 2020 on charges stemming from the illegal distribution and administration of substances to racehorses.

Kegley’s guilty plea was related to his work for Medivet, a non-FDA approved facility that manufactured and marketed a variety of questionable products for horses and other animals. Prosecutors have focused on the sale of a specific substance called SGF-1000 that sellers claimed to have a wide variety of performance-enhancing effects.

Kegley, who worked as an independent contractor for Medivet, had admitted during the entry of his guilty plea in July that he had sold the products to veterinarians and horse trainers despite knowing that they had not been approved for sale by the FDA.

As part of his agreement to plead guilty, Kegley will be required to forfeit $192,615 in “illegal proceeds” from his sales. The prosecution had initially claimed the proceeds to be in excess of $3.3 million, but the amount was reduced as part of his plea agreement, provided the payment is made within two years of his release from prison.